000 | 01908 a2200553 4500 | ||
---|---|---|---|
005 | 20250513184845.0 | ||
264 | 0 | _c19991015 | |
008 | 199910s 0 0 eng d | ||
022 | _a0007-1188 | ||
024 | 7 |
_a10.1038/sj.bjp.0702528 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSquadrito, F | |
245 | 0 | 0 |
_aTacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cMay 1999 |
||
300 |
_a498-504 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 | _aConstriction, Pathologic |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
650 | 0 | 4 |
_aMacrophages _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aPeroxidase _xmetabolism |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aShock _xmortality |
650 | 0 | 4 |
_aSplanchnic Circulation _xphysiology |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aTacrolimus _xpharmacology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aAltavilla, D | |
700 | 1 | _aSquadrito, G | |
700 | 1 | _aFerlito, M | |
700 | 1 | _aCampo, G M | |
700 | 1 | _aArlotta, M | |
700 | 1 | _aGrimaldi, S | |
700 | 1 | _aQuartarone, C | |
700 | 1 | _aSaitta, A | |
700 | 1 | _aCaputi, A P | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 127 _gno. 2 _gp. 498-504 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0702528 _zAvailable from publisher's website |
999 |
_c10343601 _d10343601 |